Medical Products

Supported by a strong commitment to science and the resources necessary for true innovation, Abbott has leading products and novel R&D capabilities focused on unmet medical needs. These include laboratory and molecular diagnostics for detecting and monitoring a wide variety of medical conditions; glucose monitoring for patients with diabetes; vascular devices such as coronary and carotid stents.

Our broad offering of medical and surgical devices focuses on minimally invasive, fast and accurate treatment options that offer short recovery times and ultimately improve patient care. Abbott's vascular business is poised for outstanding growth with support from our acquisition of Guidant Corporation's vascular intervention and endovascular solutions businesses.

Abbott is an emerging leader in molecular diagnostics, one of the most promising new areas of medicine. By analyzing DNA, RNA and proteins at the molecular level, our leading-edge science and technologies are helping physicians diagnose disease faster, select appropriate therapies and monitor disease progression. Abbott's molecular diagnostics business has gained access to significant discovery resources with the acquisition of Vysis and the long-term, strategic alliance formed with Celera.

We've made key acquisitions that have resulted in market-leading products, and we've acquired outstanding technologies for the future, such as bioabsorbable stents and continuous glucose monitoring.

Our partners have helped us support the following areas of Abbott's medical business:

Vascular Devices
Technology and/or products:	Resulting from a successful partnership with the following:
Vascular closure device	Perclose, Inc.
Carotid stent system	MedNova
Vascular devices	JOMED
Vascular closure device	Integrated Vascular Solutions, Inc.
Coronary and peripheral interventional products	Guidant
Coronary guidewires	ASAHI INTECC Co., Ltd.

 

Molecular Diagnostics and Diabetes Care
Acquired technology and/or products:	Resulting from a successful partnership with the following:
Blood glucose self-monitoring system	TheraSense
Genomic technology	Celera Diagnostics
Genomic technology	Vysis, Inc.
Infectious disease technology	Ibis Biosciences, Inc.

 

Vision Care
Acquired technology and/or products:	Resulting from a successful partnership with the following:
Corneal, refractive and cataract products	Advanced Medical Optics, Inc.